List of Tables
Table 1. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Healthcare Infection Surveillance Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Healthcare Infection Surveillance Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Healthcare Infection Surveillance Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Healthcare Infection Surveillance Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Healthcare Infection Surveillance Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Infection Surveillance Service as of 2024)
Table 11. Global Healthcare Infection Surveillance Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Healthcare Infection Surveillance Service Companies Headquarters
Table 13. Global Healthcare Infection Surveillance Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Healthcare Infection Surveillance Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Healthcare Infection Surveillance Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Healthcare Infection Surveillance Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Healthcare Infection Surveillance Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Healthcare Infection Surveillance Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Healthcare Infection Surveillance Service Growth Accelerators and Market Barriers
Table 25. North America Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Healthcare Infection Surveillance Service Growth Accelerators and Market Barriers
Table 27. Europe Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Healthcare Infection Surveillance Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Healthcare Infection Surveillance Service Investment Opportunities and Key Challenges
Table 31. Central and South America Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Healthcare Infection Surveillance Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Baxter International Inc. Corporation Information
Table 35. Baxter International Inc. Description and Major Businesses
Table 36. Baxter International Inc. Product Features and Attributes
Table 37. Baxter International Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Baxter International Inc. Revenue Proportion by Product in 2024
Table 39. Baxter International Inc. Revenue Proportion by Application in 2024
Table 40. Baxter International Inc. Revenue Proportion by Geographic Area in 2024
Table 41. Baxter International Inc. Healthcare Infection Surveillance Service SWOT Analysis
Table 42. Baxter International Inc. Recent Developments
Table 43. Wolters Kluwer Corporation Information
Table 44. Wolters Kluwer Description and Major Businesses
Table 45. Wolters Kluwer Product Features and Attributes
Table 46. Wolters Kluwer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Wolters Kluwer Revenue Proportion by Product in 2024
Table 48. Wolters Kluwer Revenue Proportion by Application in 2024
Table 49. Wolters Kluwer Revenue Proportion by Geographic Area in 2024
Table 50. Wolters Kluwer Healthcare Infection Surveillance Service SWOT Analysis
Table 51. Wolters Kluwer Recent Developments
Table 52. Gojo Industries Inc. Corporation Information
Table 53. Gojo Industries Inc. Description and Major Businesses
Table 54. Gojo Industries Inc. Product Features and Attributes
Table 55. Gojo Industries Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Gojo Industries Inc. Revenue Proportion by Product in 2024
Table 57. Gojo Industries Inc. Revenue Proportion by Application in 2024
Table 58. Gojo Industries Inc. Revenue Proportion by Geographic Area in 2024
Table 59. Gojo Industries Inc. Healthcare Infection Surveillance Service SWOT Analysis
Table 60. Gojo Industries Inc. Recent Developments
Table 61. International Business Machines Corporation Corporation Information
Table 62. International Business Machines Corporation Description and Major Businesses
Table 63. International Business Machines Corporation Product Features and Attributes
Table 64. International Business Machines Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. International Business Machines Corporation Revenue Proportion by Product in 2024
Table 66. International Business Machines Corporation Revenue Proportion by Application in 2024
Table 67. International Business Machines Corporation Revenue Proportion by Geographic Area in 2024
Table 68. International Business Machines Corporation Healthcare Infection Surveillance Service SWOT Analysis
Table 69. International Business Machines Corporation Recent Developments
Table 70. Premier Inc. Corporation Information
Table 71. Premier Inc. Description and Major Businesses
Table 72. Premier Inc. Product Features and Attributes
Table 73. Premier Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Premier Inc. Revenue Proportion by Product in 2024
Table 75. Premier Inc. Revenue Proportion by Application in 2024
Table 76. Premier Inc. Revenue Proportion by Geographic Area in 2024
Table 77. Premier Inc. Healthcare Infection Surveillance Service SWOT Analysis
Table 78. Premier Inc. Recent Developments
Table 79. Alpha Source Inc. Corporation Information
Table 80. Alpha Source Inc. Description and Major Businesses
Table 81. Alpha Source Inc. Product Features and Attributes
Table 82. Alpha Source Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Alpha Source Inc. Recent Developments
Table 84. RLDatixS. C. Corporation Information
Table 85. RLDatixS. C. Description and Major Businesses
Table 86. RLDatixS. C. Product Features and Attributes
Table 87. RLDatixS. C. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. RLDatixS. C. Recent Developments
Table 89. BD Corporation Information
Table 90. BD Description and Major Businesses
Table 91. BD Product Features and Attributes
Table 92. BD Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. BD Recent Developments
Table 94. BioVigil Corporation Information
Table 95. BioVigil Description and Major Businesses
Table 96. BioVigil Product Features and Attributes
Table 97. BioVigil Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. BioVigil Recent Developments
Table 99. Johnson & Son Corporation Information
Table 100. Johnson & Son Description and Major Businesses
Table 101. Johnson & Son Product Features and Attributes
Table 102. Johnson & Son Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Johnson & Son Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Healthcare Infection Surveillance Service Product Picture
Figure 2. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Bloodstream Infections Product Picture
Figure 4. Surgical Site Infections Product Picture
Figure 5. Gastrointestinal Infections Product Picture
Figure 6. Urinary Tract Infections (UTI) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Hospitals & Clinics
Figure 10. Ambulatory Surgical Centers
Figure 11. Academic Institutes
Figure 12. Others
Figure 13. Healthcare Infection Surveillance Service Report Years Considered
Figure 14. Global Healthcare Infection Surveillance Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 16. Global Healthcare Infection Surveillance Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global Healthcare Infection Surveillance Service Revenue Market Share by Region (2020-2031)
Figure 18. Global Healthcare Infection Surveillance Service Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Bloodstream Infections Revenue Market Share by Player in 2024
Figure 21. Surgical Site Infections Revenue Market Share by Player in 2024
Figure 22. Gastrointestinal Infections Revenue Market Share by Player in 2024
Figure 23. Urinary Tract Infections (UTI) Revenue Market Share by Player in 2024
Figure 24. Others Revenue Market Share by Player in 2024
Figure 25. Global Healthcare Infection Surveillance Service Revenue Market Share by Type (2020-2031)
Figure 26. Global Healthcare Infection Surveillance Service Revenue Market Share by Application (2020-2031)
Figure 27. North America Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
Figure 29. North America Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
Figure 31. US Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 32. Canada Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 33. Mexico Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 34. Europe Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
Figure 35. Europe Top 5 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
Figure 36. Europe Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020-2031)
Figure 37. Europe Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
Figure 38. Germany Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 39. France Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 40. U.K. Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 41. Italy Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 42. Russia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
Figure 44. Asia-Pacific Top 8 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
Figure 45. Asia-Pacific Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020-2031)
Figure 46. Asia-Pacific Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
Figure 47. Indonesia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 48. Japan Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 49. South Korea Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 50. Australia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 51. India Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 52. Indonesia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 53. Vietnam Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 54. Malaysia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 55. Philippines Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 56. Singapore Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
Figure 57. Central and South America Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Central and South America Top 5 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
Figure 59. Central and South America Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020-2031)
Figure 60. Central and South America Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
Figure 61. Brazil Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
Figure 62. Argentina Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
Figure 63. Middle East and Africa Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Middle East and Africa Top 5 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
Figure 65. South America Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020-2031)
Figure 66. Middle East and Africa Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
Figure 67. GCC Countries Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
Figure 68. Israel Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
Figure 69. Egypt Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
Figure 70. South Africa Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
Figure 71. Healthcare Infection Surveillance Service Industry Chain Mapping
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed